EANS-DD: Marinomed Biotech AG / Notification concerning transactionsby persons performing managerial responsibilities pursuant toarticle 19 Market Abuse Regulation (MAR)

81

Directors‘ Dealings-Announcement pursuant to artikle 19 MAR transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement.

personal data:

responsible party:

name: Invest Unternehmensbeteiligungs Aktiengesellschaft Europaplatz 5a, 4020 Linz (legal person)

——————————————————————————–

reason:

reason: responsible party is a legal person associate to a person with managerial responsibilities
name and surname: Dr. Gernot Hofer
function: Member of an administrative or supervisory board

——————————————————————————–

issuer information:

name: Marinomed Biotech AG
Legal Entity Identifier (LEI): 529900GN3B1EN80XF405

——————————————————————————–

information about deal:

ISIN: ATMARINOMED6
description of the financial instrument: Stock
type: acquisition
date: 01.02.2019; UTC+01:00
market: WIENER BOERSE AG, XWBO
currency: Euro

price volume
75 6666

total volume: 6666
total price: 499950
average price: 75

——————————————————————————–

end of announcement euro adhoc

issuer: Marinomed Biotech AG
Veterinärplatz 1
A-1210 Wien
phone: 0043250774460
FAX: 0043250774493
mail: office@marinomed.com
WWW: www.marinomed.com
ISIN: ATMARINOMED6, AT0000A1WD52
indexes:
stockmarkets: Wien
language: English

Digital press kit: http://www.ots.at/pressemappe/31479/aom

OTS-ORIGINALTEXT PRESSEAUSSENDUNG UNTER AUSSCHLIESSLICHER INHALTLICHER VERANTWORTUNG DES AUSSENDERS. www.ots.at
© Copyright APA-OTS Originaltext-Service GmbH und der jeweilige Aussender

Weiterlesen..